iASPP, A potential drug target in cancer therapy

Leukemia Research

Volumn 33, Issue 9, 2009, Pages 1175-1177

  Gillotin, Sébastien ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DAUNORUBICIN; ETOPOSIDE; PROTEIN ASPP1; PROTEIN ASPP2; PROTEIN IASPP; PROTEIN P53; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; APOPTOSIS; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; DISEASE MODEL; DOWN REGULATION; DRUG TARGETING; EDITORIAL; GENE MUTATION; HETEROZYGOSITY; HUMAN; LEUKEMIA REMISSION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE;

HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NEOPLASMS;

EID: 67549086088     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.04.037     Document Type: Editorial

References (19)

1. Yang J.P., Hori M., Takahashi N., Kawabe T., Kato H., and Okamoto T. NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 18 37 (1999) 5177-5186
2. Slee E.A., Gillotin S., Bergamaschi D., Royer C., Llanos S., Ali S., et al. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. Oncogene 23 56 (2004) 9007-9016
3. Bergamaschi D., Samuels Y., O'Neil N.J., Trigiante G., Crook T., Hsieh J.K., et al. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 33 2 (2003) 162-167
4. Trigiante G., and Lu X. ASPP [corrected] and cancer. Nat Rev Cancer 6 3 (2006) 217-226
5. Samuels-Lev Y., O'Connor D.J., Bergamaschi D., Trigiante G., Hsieh J.K., Zhong S., et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8 4 (2001) 781-794
6. Bergamaschi D., Samuels Y., Jin B., Duraisingham S., Crook T., and Lu X. ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol 24 3 (2004) 1341-1350
7. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr. C.A., Butel J.S., et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 6366 (1992) 215-221
8. Vives V., Su J., Zhong S., Ratnayaka I., Slee E., Goldin R., et al. ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes Dev 20 10 (2006) 1262-1267
9. Liu Z.J., Zhang Y., Zhang X.B., and Yang X. Abnormal mRNA expression of ASPP members in leukemia cell lines. Leukemia 18 4 (2004) p880
10. Liu Z.J., Lu X., Zhang Y., Zhong S., Gu S.Z., Zhang X.B., et al. Downregulated mRNA expression of ASPP and the hypermethylation of the 5′-untranslated region in cancer cell lines retaining wild-type p53. FEBS Lett 579 7 (2005) 1587-1590
11. Agirre X., Roman-Gomez J., Jimenez-Velasco A., Garate L., Montiel-Duarte C., et al. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene 25 13 (2006) 1862-1870
12. Zhang X., Wang M., Zhou C., Chen S., and Wang J. The expression of iASPP in acute leukemias. Leuk Res 29 2 (2005) 179-183
13. Nexo B.A., Vogel U., Olsen A., Nyegaard M., Bukowy Z., Rockenbauer E., et al. Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP. BMC Med Genet 9 (2008) p56
14. Lu X. p53: a heavily dictated dictator of life and death. Curr Opin Genet Dev 15 1 (2005) 27-33
15. Laska M.J., Strandbygard D., Kjeldgaard A., Mains M., Corydon T.J., Memon A.A., et al. Expression of the RAI gene is conducive to apoptosis: studies of induction and interference. Exp Cell Res 313 12 (2007) 2611-2621
16. Takahashi N., Kobayashi S., Jiang X., Kitagori K., Imai K., Hibi Y., et al. Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene by alternative splicing. Biochem Biophys Res Commun 315 2 (2004) 434-438
17. Zhang X., Diao S., Rao Q., Xing H., Liu H., Liao X., et al. Identification of a novel isoform of iASPP and its interaction with p53. J Mol Biol 368 4 (2007) 1162-1171
18. Robinson R.A., Lu X., Jones E.Y., and Siebold C. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73. Structure 16 2 (2008) 259-268
19. Ahn J., Byeon I.J., Byeon C.H., and Gronenborn A.M. Insight into the structural basis of pro- and anti-apoptotic p53 modulation by ASPP proteins. J Biol Chem (2009)